No Data
No Data
Kringl, Reprocell, and others.
<2164>The regional newspaper company's shareholder benefit program has been significantly changed (expanded) <4075>Brains has completed the acquisition of its own shares <4397>TeamSpirit, primarily engaged in the development and sale of the "Work Life Log" SaaS business, has acquired the stocks of Work Life Log, making it a wholly-owned subsidiary and merging with it <4884>Kringl has obtained a first-class Pharmaceutical manufacturing and sales license <4978>Reprocell has acquired and retired all remaining subscription rights from the 16th series (with exercise price revision clauses and exercise permission clauses).
Stocks that moved the day before part 2: Liberata, Kyuso Distribution System, BTM, etc.
Stock name <Code> 10-day closing price ⇒ Compared to the previous day PeptiDream <4587> 2347.5 -691, breaking through the November low, selling pressure from short positions is dominant. Kewpie <2809> 3100 -123, Q4 results and this fiscal year's guidance are below market expectations. Onward HD <8016> 588 -14, viewing the cumulative operating profit for Q3 as a negative due to a double-digit decrease. T&D HD <8795> 2794.5 -711, on the 10th, sell-offs concentrated on financial-related stocks. Chugai Pharmaceutical <4519>
Emerging Markets stock digest: Ski resort development has rebounded significantly, Heartseed has fallen sharply.
<4388> Aeye Inc 516 +7 rebounded. It has been announced that they will start providing a trial version of the integrated SDK (Software Development Kit) for AI voice synthesis and speech recognition, named the embedded voice dialogue framework SLFramework (provisional), which is seen as a positive development. SLFramework is an embedded SDK that enables voice input and output for applications and services, featuring a speech recognition engine that recognizes and converts the user's spoken content into text.
Stocks that moved or were traded in the first half of the session.
*Kyukoh Pharmaceutical <4530> 4610 +566 Profit increase significantly expanded due to upward revision of earnings. *Sankyo Gosei <7888> 675 +69 The significant profit increase in the first half is highly regarded. *Sansan <4443> 2345 +146 Today, some small and medium-sized growth stocks are stable with Earnings Reports expected after the holiday. *Round One <4680> 1221 +6412 The stock price drop received in December is viewed as an overreaction. *Warabeya Nichiyo <2918> 2109 +1079 The operating profit increased in the November period.
Hot Stocks Digest (Morning Session): Fast Retailing, OSG, Heartseed, ETC.
Significant decline. The third quarter financial results were announced the previous day, showing an operating profit of 11.4 billion yen for the 9-11 month period, which is a 16.8% increase compared to the same period last year, but it fell short of market estimates of around 12 billion yen.
Reprocell --- Announced the conclusion of a Dealers contract with Qkine.
Stalemate. After the close of trading on the 9th, it was announced that a Dealers contract was signed with Qkine, leading to an initial buying push, but the upper limits remain heavy. The company and its group have signed an agency agreement with Qkine, a manufacturer specializing in high-performance proteins based in Cambridge, UK. This agreement allows for the sales development of high-quality growth factors and cytokines produced by Qkine. Qkine's products are highly regarded for their features such as being free of animal-derived raw materials, high purity, and high activity.